What is GlauCAT™️-Asian?
GlauCATTM-Asian measures the impact of glaucoma, associated vision loss and glaucoma treatments, using computerized adaptive testing (CAT), on 7 domains of quality of life including:
Ocular comfort – 16 items
Activity limitation – 56 items
Lighting – 15 items
Mobility – 19 items
Glaucoma management – 28 items
Psychosocial – 32 items
Concerns – 16 items
GlauCATTM-Asian has been developed and validated in patients with glaucoma in Singapore and is currently available for use.
![download (1)](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_296,h_170/https://prominsight.com/wp-content/uploads/2022/02/download-1.jpeg)
Publications
![Phase1 Phase1](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_400,h_300/https://prominsight.com/wp-content/uploads/2020/09/P-1.png)
Domain and item development and refinement
Qualitative interviews with patients and experts in the field.
![P-3a pilot-testing](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_400,h_300/https://prominsight.com/wp-content/uploads/2020/12/P-3a.png)
Pilot testing
Psychometric testing of item banks in a large sample of patients with glaucoma in Singapore.